ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PHAR vs IVA // ENTERPRISE SCALE & MARKET CAP

Pharming Group N.V. ADS each representing 10 (NASDAQ) VS. Inventiva S.A. American Depository Shares (NASDAQ) • 15-METRIC TALLY: PHAR 2 — IVA 0
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PHAR
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PHAR VS. IVA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PHAR IVA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality — — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 69.1 53.2 +15.90 PHAR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $863.7M $862.4M $1.3M PHAR /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PHAR REV IVA REV PHAR GROSS % IVA GROSS % PHAR FCF IVA FCF
INSPECT INDIVIDUAL XBRL MODELS AT PHAR FA <GO> AND IVA FA <GO>.
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PHAR // BETA —
IVA // BETA —